World-class
Scientific Advisory

Work with Richmond Pharmacology and trust your experience will be personal and truly strategic.

Emma Akuffo, BSc, PhD
Director of Study Management

Emma oversees the Study Management, Advanced Research Science and Quality Assurance teams at Richmond Pharmacology.

During her 10 years at Richmond Pharmacology, Emma has worked on over 100 Early Phase Studies ensuring optimal delivery of clinical trial outcomes for our sponsors. This has been achieved through efficient, streamlined processes, the production of high quality documentation and stringent regulatory compliance.

Prior to working at Richmond Pharmacology, Emma worked on various drug development projects within the biotechnology and pharmaceutical industry as well as academia.

Emma is a full member of the British Pharmacological Society and holds a BSc in Biology & Chemistry, PhD in Biochemistry and Postgraduate Certificate in Business Administration.

Back to experts

Latest news

Upcoming Event

ACCP 2020, Translating Clinical Pharmacology Research into Patient-centered Care

21 - 23 September 2020
Dr. Jorg Taubel will be presenting posters that explore the subjects of cardiac health and diabetes.
View event

Richmond Pharmacology is delighted to confirm partnership with Intellia Therapeutics

October 20, 2020
Phase I study of Intellia Therapeutic’s NTLA-2001 for the treatment of hereditary transthyretin amyloidosis with polyneuropathy (hATTR-PN)
Read more

Richmond Pharmacology supports ReViral with the development of Sisunatovir

September 9, 2020
ReViral has confirmed the FDA has granted Fast Track designation to Sisunatovir.
Read more

Richmond Pharmacology helps UK patients gain early access to ultra-rare disease drug Lumasiran

August 17, 2020
Richmond Pharmacology early phase drug development update.
Read more